Differences between metabolically healthy and unhealthy obesity in PAI-1 levelLourdes Basurto, Carlos Martı́nez-Murillo, L. Fuentes Sánchez et al.|Thrombosis Research|2019Cited by 23
COVID‐19 in a country with a very high prevalence of diabetes: The impact of admission hyperglycaemia on mortalityCarlos Martı́nez-Murillo, Juan Zazueta, Christian Omar Ramos Peñafiel et al.|Endocrinology Diabetes & Metabolism|2021Cited by 10
Circulating levels of plasminogen activator inhibitor-1 are associated with metabolic syndrome rather than with menopauseLourdes Basurto, Carlos Martı́nez-Murillo, Alma Díaz et al.|Gynecological Endocrinology|2019Cited by 8
Women and COVID-19: severity and mortality in hospitalized middle-aged and older patientsLourdes Balcázar‐Hernández, Lourdes Basurto, Christian Omar Ramos Peñafiel et al.|Climacteric|2021Cited by 7
Thrombotic risk assessed by PAI-1 in patients with COVID-19: The influence of hyperglycemia and diabetes mellitusLourdes Basurto, Juan Carlos Anda‐Garay, Leticia Manuel‐Apolinar et al.|Clínica e Investigación en Arteriosclerosis|2024Cited by 4